Sample Press Release #4 – Free Screening Program FOR IMMEDIATE RELEASE CONTACT: (Name) (Phone Number) (Email address – if appropriate) (Practice Name) Offers Free Eye Exams to Low-Income Families (OR Underprivileged Children or Children…) in (Area or State) Exams Will Feature New Ocular Screening Device – the optomap® Retinal Exam (City), (State)/(Date) – In an effort to provide access to quality eye care, (Practice Name) will offer free eye exams to INSERT GROUP in (area or state), which will include the revolutionary new screening test, the optomap® Retinal Exam. “Regular eye exams are crucial for people of all ages in order to attain good vision and detect eye disease and damage early in order to prevent unnecessary vision loss,” said (Doctor Name), (Practice Name). “Unfortunately there are many medically underserved people in (Your area or state) that are unable to get the proper eye care they need due to their financial situation or the fact that they are uninsured. My goal is to help these people by providing free eye exams to qualified individuals and their families.” (Practice Name) is (either “the only” or “one of few”) practices in the (area or state) using a revolutionary new screening system, the optomap® Retinal Exam, which captures and analyzes an image of virtually the entire retina. Since Optos introduced the exam, millions of exams have been conducted worldwide, diagnosing serious eye conditions – such as diabetic retinopathy, retinal detachments and macular degeneration that would have otherwise gone undetected.
The optomap® Retinal Exam reveals important information for the comprehensive evaluation of systemic and ocular health. The 200 degree internal scan is captured in a quarter of a second and is performed as an initial step in a comprehensive eye exam, giving practitioners a tool to help discover retinal disease. This offers an assisted opportunity to diagnose eye conditions – as well as other health conditions – early. Importantly, it enables the practitioner to effectively determine the next course of action.
Some Facts About Eye Disease More than 1.1 million Americans are legally blind. An additional 50,000 people lose their sight each year, yet nearly half of all blindness can be prevented. Blindness is the number one complication of people with diabetes – diabetic retinopathy is one of the leading causes of new cases of blindness with an average of 8,000 new cases each year. People over the age of 65 have a 30 percent chance of developing age related macular degeneration (AMD), which gradually destroys sharp, central vision. AMD is the leading cause of blindness for those aged 55 and older in the U.S. Every five seconds one person in the world goes blind. A child goes blind every minute. About (Practice Name) (Practice Name) located in (City, State) is a (Insert two or three sentences describing your practice). For more information on how to qualify for a free eye exam, contact (Your Name) at (Phone Number).
About Optos Millions of optomap® exams have been conducted world wide, aiding in the detection and diagnosis of serious eye conditions such as diabetic retinopathy,
retinal detachments, macular degeneration, and other pathologies like melanomas. Over 10,000 optomap® Retinal Exams are conducted daily at thousands of sites throughout North America.
Optos is a provider of innovative solutions for comprehensive retinal evaluation, enabling practitioners to more effectively detect, monitor and promote patient health. The optomap® Retinal Exam is an integral first step in the clinical evaluation of every patient annually. It non-invasively generates an instantaneous, ultra-widefield digital scan of the retina, revealing important information for the comprehensive evaluation of systemic and ocular health.
Optos plc is a leading and rapidly growing medical technology company for the design, development, manufacturing and marketing of devices that image the retina, the light-sensitive area at the back of the eye. Optos’ platform technology is the Panoramic200 Scanning Laser Ophthalmoscope device - known as the P200. In a quarter of a second the P200 device produces a high resolution image of up to 200 degrees or approximately 82 percent of the retina in a single capture. The image branded the optomap® Retinal Exam - provides eye care practitioners with clinically useful information that facilitates the early detection of disorders and diseases evidenced in the retina, such as glaucoma, diabetic retinopathy and age-related macular degeneration. Retinal imaging can also indicate evidence of non-eye or systemic diseases such as diabetes, hypertension and certain cancers. The Company has recently gained regulatory clearance (CE and FDA 510(k)) to market a second device - P200MA. Optos’ technology provides an unequalled combination of widefield retinal imaging, speed and convenience for both practitioner and patient and can help save sight and save lives.
###